GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 196 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q4 2018. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $20,000 | +100.0% | 300 | 0.0% | 0.01% | +116.7% |
| Q2 2022 | $10,000 | -28.6% | 300 | -38.5% | 0.01% | -14.3% |
| Q4 2021 | $14,000 | +16.7% | 488 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $12,000 | -29.4% | 488 | 0.0% | 0.01% | -22.2% |
| Q2 2021 | $17,000 | -51.4% | 488 | -43.5% | 0.01% | -55.0% |
| Q1 2021 | $35,000 | -12.5% | 863 | -6.7% | 0.02% | -28.6% |
| Q4 2020 | $40,000 | -31.0% | 925 | 0.0% | 0.03% | -52.5% |
| Q2 2020 | $58,000 | +23.4% | 925 | 0.0% | 0.06% | -1.7% |
| Q1 2020 | $47,000 | +4.4% | 925 | 0.0% | 0.06% | +106.9% |
| Q3 2019 | $45,000 | +36.4% | 925 | +48.0% | 0.03% | +31.8% |
| Q2 2019 | $33,000 | 0.0% | 625 | 0.0% | 0.02% | -12.0% |
| Q1 2019 | $33,000 | +32.0% | 625 | -5.0% | 0.02% | +108.3% |
| Q3 2018 | $25,000 | – | 658 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |